Cranberry Supplementation, Viral Defense, Antibody Response to the Flu Shot

NCT04597554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2022-02-21

No results posted yet for this study

Summary

This study will investigate the effect of 8-weeks cranberry supplementation on the antibody response to influenza vaccination and ex-vivo anti-viral activity. The hypothesis is that 8-weeks ingestion of cranberry supplement relative to placebo will improve the antibody response to influenza vaccination and ex-vivo anti-viral defense.

Conditions

  • Nutrition Immunology

Interventions

DIETARY_SUPPLEMENT

Cranberry

Cranberry beverage and gummies supplement

DIETARY_SUPPLEMENT

Placebo

Placebo beverages and gummies supplement

Sponsors & Collaborators

  • Ocean Spray, Inc.

    collaborator INDUSTRY
  • Appalachian State University

    lead OTHER

Principal Investigators

  • David C Nieman · Appalachian State Univ

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-21
Primary Completion
2020-11-30
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04597554 on ClinicalTrials.gov